About Niostem
Niostem is a company based in Koln (Germany) founded in 2019 by Emil Aliev and Carlos A Chacon Martinez. Niostem has raised $1.94 million across 1 funding round from investors including Brightlands Venture Partners. Niostem offers products and services including niostem Wearable. Niostem operates in a competitive market with competitors including Avita Medical, Quality by Design, Suneva Medical, MoMelan Technologies and LifeCell, among others.
- Headquarter Koln, Germany
- Founders Emil Aliev, Carlos A Chacon Martinez
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mane Biotech Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.94 M (USD)
in 1 rounds
-
Latest Funding Round
$1.94 M (USD), Seed
Jan 18, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Niostem
Niostem offers a comprehensive portfolio of products and services, including niostem Wearable.
Uses bioelectrical stimulation to promote hair follicle growth and density.
People of Niostem
Unlock access to complete
Unlock access to complete
Funding Insights of Niostem
Niostem has successfully raised a total of $1.94M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.94 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Niostem
Niostem has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Brightlands Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Brightlands Venture Partners is focused on venture capital investments.
|
Locked | Locked | Locked |
Investor details for Niostem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Niostem
Investment portfolio details for Niostem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Niostem
Detailed financials for Niostem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Niostem Comparisons
Peer comparison for Niostem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Niostem
Niostem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avita Medical, Quality by Design, Suneva Medical, MoMelan Technologies and LifeCell, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Products for regenerative and respiratory medicine are developed and distributed.
|
|
| Locked | Locked | Locked |
Medical grade collagen components are developed and manufactured.
|
|
| Locked | Locked | Locked |
Novel aesthetic products for regenerative markets are developed and commercialized.
|
|
| Locked | Locked | Locked |
Skin grafting technology for dermatological diseases and wound care
|
|
| Locked | Locked | Locked |
Tissue repair products for regenerative medicine are developed and marketed.
|
Detailed competitors of Niostem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Niostem
Complete news archive for Niostem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Niostem
Niostem was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Niostem is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.
Carlos A Chacon Martinez is the current CEO of Niostem. They have also founded this company.
Niostem is a funded company, having raised a total of $1.94M across 1 funding round to date.
Provider of smart wearable device to regrow hair. The company has developed nio1 a smart wearable device to combat pattern baldness that uses low-level bioelectrical stimulation to the scalp to trigger the natural growth cycle of the body.
Niostem's top competitors include Avita Medical, Quality by Design and Suneva Medical.
Niostem offers niostem Wearable.
Niostem has 1 investor. Key investors include Brightlands Venture Partners.